adike / shutterstock.com
12 September 2019GeneticsRory O'Neill
University of Columbia and Illumina locked in DNA patent battle
The University of Columbia has hit Illumina with a patent infringement suit relating to next-generation DNA sequencing, just days after the pharmaceutical company had one of the university’s patents invalidated at the US Patent and Trial Appeal Board (PTAB).
